Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 331,601	$ 1,174,608
Prepaid expenses and other current assets	316,576	1,499,219
Short-term notes receivable, net of allowance for credit losses of $828,000 at June 30, 2025 and $360,000 at December 31, 2024	3,312,496	2,010,692
Total current assets	3,960,673	4,684,519
Other assets	2,000	2,000
Total Assets	3,962,673	4,686,519
Current liabilities
Accounts payable	1,404,611	1,568,065
Accrued expenses and other current liabilities	379,633	170,243
Warrant liabilities	213,976	269,175
Convertible debt	142,069
Promissory notes	3,474,667
Total current liabilities	5,614,956	2,007,483
Commitments and Contingencies (Note 10)
Stockholders’ Equity (Deficit)
Preferred stock, $0.001 par value; 15,000,000 shares authorized; 2,984 and 6,256 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	2,790,007	5,716,400
Common stock, $0.001 par value; 225,000,000 shares authorized; 1,635,475 and 736,431 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	66,213	65,314
Additional paid-in capital	122,884,659	119,958,897
Accumulated deficit	(127,393,162)	(123,061,575)
Total Stockholders’ Equity (Deficit)	(1,652,283)	2,679,036
Total Liabilities & Stockholders’ Equity (Deficit)	$ 3,962,673	$ 4,686,519